RANZCR invites stakeholder consultation on newly developed guidelines addressing patient consent for Artificial Intelligence (AI) applications in clinical practice. As AI systems become increasingly embedded in medical imaging and treatment planning, these guidelines provide essential safeguards to ensure ethical implementation.
The guidelines advocate maintaining meaningful human control. It establishes tiered consent processes based on the potential impact of the AI tool, with particular attention to systems that directly influence diagnosis or treatment pathways. The guidelines recognise AI's potential to enhance care delivery while establishing necessary boundaries to protect patient safety and consent.
This consultation represents an important opportunity for stakeholders to shape the responsible adoption of AI in healthcare.
Submissions will be accepted until 24 September 2025, with final guidelines anticipated for publication in December 2025.
Documentation: Patient consent for the use of AI in clinical radiology and radiation oncology
For further information, or to submit your feedback, please contact This email address is being protected from spambots. You need JavaScript enabled to view it., referencing line numbers where appropriate.